Trials / Unknown
UnknownNCT00821275
Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma
Multi-Center Clinical Trial of Uterine Artery Embolization Treatment of Uterine Leiomyoma
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 900 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The efficacy and safety of uterine artery embolization, as compared with standard surgical methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of this trial is to evaluate the uterine volume and tumor size reduction, symptomatic relief, complication, fertility, ovarian function and quality of life with uterine artery embolization for uterine fibroids comparing with standard surgical methods.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Interventional radiological or surgical management | Uterine artery embolization will be done for the patients who enroll into UAE group and desire for future pregancy and reserving uterus.Myomectomy will be performed for the patients who enroll into SURGERY group and desire for future pregancy and reserving uterus.Hysterectomy will be done for the patients who enroll into SURGERY group and don't desire for reserving uterus and/or future pregnancy. |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2009-01-13
- Last updated
- 2009-01-13
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00821275. Inclusion in this directory is not an endorsement.